Immune complex–driven neutrophil activation and BAFF release: a link to B cell responses in SLE

Immune complex–driven neutrophil activation and BAFF release: a link to B cell responses in SLE

Objective The role of neutrophils in driving pathogenic B cell responses in SLE is not fully understood. In this study, we explored the link between immune complex (IC)–driven neutrophil activation, the release of B cell pro-survival factor BAFF and B cell activation using SLE clinical samples.Metho...

Full description

Bibliographic Details
Main Authors:	Ting Wang, Christian Lood, Sladjana Skopelja-Gardner, Andrew Vasconcellos, John Marken, Natalia V Giltiay
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-07-01
Series:	Lupus Science and Medicine
Online Access:	https://lupus.bmj.com/content/9/1/e000709.full

Similar Items

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease
by: Daniela Giordano, et al.
Published: (2023-02-01)

SLE and alpha-SLE driven by Levy processes
by: Guan, Q, et al.
Published: (2008)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models.
by: Gavin, A, et al.
Published: (2005)

P17 Autophagy- based unconventional secretion of B cell activating factor (BAFF) by monocytes in Systemic Lupus Erythematosus (SLE)
by: Prodromos Sidiropoulos, et al.
Published: (2024-03-01)

LSO-057 Association between TNFSF13B gene polymorphism and serum BAFF levels with disease activity in SLE patients
by: Laniyati Hamijoyo, et al.
Published: (2023-07-01)

An IL-1β-driven neutrophil–stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma
by: de Jong, MME, et al.
Published: (2024)

Association of BAFF and BAFF-R polymorphisms with sarcoidosis in a Greek patient cohort
by: Maria Martinou, et al.
Published: (2022-10-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

P26 In remitted SLE patients BAFF/BLyS serum levels measured at the time of immunosuppressant discontinuation are higher in patients with subsequent flares
by: Andrea Doria, et al.
Published: (2024-03-01)

Excessive miR-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression
by: Shuangyan Luo, et al.
Published: (2019-05-01)

Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics
by: Jenny Hu, et al.
Published: (2014-02-01)

High TLR7 Expression Drives the Expansion of CD19+CD24hiCD38hi Transitional B Cells and Autoantibody Production in SLE Patients
by: Ting Wang, et al.
Published: (2019-06-01)

LP-091 Neutrophil extracellular traps in APS and SLE
by: Tatiana Reshetnyak, et al.
Published: (2023-07-01)

The BAFF-APRIL System in Cancer
by: Md Ashik Ullah, et al.
Published: (2023-03-01)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice.
by: Tamara Möckel, et al.
Published: (2023-01-01)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice
by: Tamara Möckel, et al.
Published: (2023-01-01)

PO.5.110 Plasma levels of osteopontin in SLE
by: M Compagno, et al.
Published: (2022-10-01)

Overexpression of the Cytokine BAFF and Autoimmunity Risk.
by: Steri, M, et al.
Published: (2017)

Evaluating the Link between BAFF System Gene Expression and Acute Rejection Development in Kidney Transplantation
by: Rafael Alfaro, et al.
Published: (2022-07-01)

Association of BAFF gene polymorphisms with multiple sclerosis progression
by: I. V. Smagina, et al.
Published: (2020-02-01)

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
by: Lucas L. van den Hoogen, et al.
Published: (2022-12-01)

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest
by: Martina Rossi, et al.
Published: (2023-04-01)

BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth
by: Jessica R. Doll, et al.
Published: (2023-04-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

The role of C1q and apoptotic bridging molecules in the recognition and clearance of apoptotic neutrophils in SLE.
by: Donnelly, S, et al.
Published: (2002)

The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps
by: Brendan Antiochos, et al.
Published: (2022-05-01)

Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension
by: Akrivi Chrysanthopoulou, et al.
Published: (2021-09-01)

Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease
by: Marko Kumric, et al.
Published: (2021-12-01)

The levels of BAFF and regulatory B cells and their association with systemic lupus erythematosus
by: Zhi-xuan GUO, et al.
Published: (2020-04-01)

LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE)
by: Yuko Kaneko, et al.
Published: (2023-07-01)

ADE and SLE
by: Cardy, J
Published: (2007)

Hormones, immune response, and pregnancy in healthy women and SLE patients.
by: M Zen, et al.
Published: (2010-04-01)

EZH2: Its regulation and roles in immune disturbance of SLE
by: Yiying Yang, et al.
Published: (2022-10-01)

The effect of prolactin on immune cell subsets involved in SLE pathogenesis
by: Maria Victoria Legorreta-Haquet, et al.
Published: (2022-10-01)

An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia
by: Md Ashik Ullah, et al.
Published: (2024-02-01)

The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
by: Chee Kay Cheung, et al.
Published: (2024-02-01)

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

Pulmonary-renal vasculitis syndrome, probably due to immune complexes (SLE)
by: Claudia Roche Albernas, et al.
Published: (2011-04-01)